Article

Cataract patients tolerate tobramycin and dexamethasone suspension four times daily

Barcelona, Spain-A combination eye-drop formulation of tobramycin and dexamethasone suspension (TobraDex, Alcon) is safe and well tolerated in patients when administered four times daily to control inflammation following cataract surgery.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Related Content
(Image credit: AdobeStock/racesy) Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
August 27th 2025

Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting

3 Things You Should Know About the GA Pipeline
August 27th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Surgical innovation in dry eye disease: Salivary gland transplant
August 27th 2025

Surgical innovation in dry eye disease: Salivary gland transplant

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 27th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

First patient dosed in Qlaris Bio's phase 2 Nightingale clinical trial for QLS-111
August 27th 2025

First patient dosed in Qlaris Bio's phase 2 Nightingale clinical trial for QLS-111

OCT changes with low-level red light therapy for myopia in children
August 27th 2025

OCT changes with low-level red light therapy for myopia in children

© 2025 MJH Life Sciences

All rights reserved.